Amlodipine Besylate And Olmesartan Medoxomil Tablet
Product Images NDC 27241-084

10 FDA label images from Ajanta Pharma Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate And Olmesartan Medoxomil (NDC 27241-084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Amlodipine And Olmesartan Fig1)

Figure1 (Amlodipine And Olmesartan Fig1)
A line graph showing the probability of achieving diastolic blood pressure (DBP) below 90 mmHg plotted against baseline DBP (mmHg) for four treatment groups: placebo, Amlodipine 10 mg (AML 10 mg), Olmesartan medoxomil 40 mg (OM 40 mg), and the combination of Amlodipine/Olmesartan 10/40 mg (AML/OM 10/40 mg). Percent DBP < 90 mmHg decreases as baseline DBP increases for all groups, with the combination treatment having the highest probability throughout the range.*
FDA Label Image

Figure2 (Amlodipine And Olmesartan Fig2)

Figure2 (Amlodipine And Olmesartan Fig2)
A line graph showing the probability of achieving diastolic blood pressure (DBP) < 90 mmHg at week 8 relative to baseline systolic blood pressure (SBP) in mmHg. Four curves represent different treatments: placebo, AML 10 mg, OM 40 mg, and AML/OM 10/40 mg combination. The y-axis shows the percentage with SBP <140 mmHg, and the x-axis shows baseline SBP values from 140 to 180 mmHg.*
FDA Label Image

Figure3 (Amlodipine And Olmesartan Fig3)

Figure3 (Amlodipine And Olmesartan Fig3)
This line graph shows the probability of achieving diastolic blood pressure (DBP) < 80 mmHg relative to baseline DBP (mmHg) for different treatments: Placebo, AMLODIPINE (AML) 10 mg, OLMESARTAN MEDOXOMIL (OM) 40 mg, and a combination AML/OM 10/40 mg. The vertical axis represents the percentage achieving DBP < 80 mmHg, and the horizontal axis is baseline DBP from 95 to 110 mmHg.*
FDA Label Image

Figure4 (Amlodipine And Olmesartan Fig4)

Figure4 (Amlodipine And Olmesartan Fig4)
A line graph showing the probability of achieving diastolic blood pressure (DBP) below 80 mmHg at week 8 using LOCF analysis, plotted against baseline systolic blood pressure (SBP) measured in mmHg. The graph compares four groups: Placebo, Amlodipine besylate 10 mg, Olmesartan medoxomil 40 mg, and a combination of Amlodipine besylate 10 mg with Olmesartan medoxomil 40 mg, illustrating higher probabilities with the combination treatment across the SBP range 140 to 180 mmHg.*
FDA Label Image

Amlodipine-structure (Amlodipine And Olmesartan1)

Amlodipine-structure (Amlodipine And Olmesartan1)
Chemical structure of amlodipine besylate and olmesartan medoxomil, illustrating the molecular composition and arrangement of the active ingredients in this prescription drug formulation.*
FDA Label Image

Olmesartan-structure (Amlodipine And Olmesartan2)

Olmesartan-structure (Amlodipine And Olmesartan2)
Chemical structure diagram of the active ingredient Olmesartan medoxomil, showing its molecular framework with labeled chemical groups and bonds.*
FDA Label Image

5mg-20mg (Amlodipine And Olmesartan 5 20mg)

5mg-20mg (Amlodipine And Olmesartan 5 20mg)
Label for Amlodipine and Olmesartan Medoxomil Tablets, USP, 5 mg/20 mg strength. The label indicates a bottle of 30 tablets, manufactured by Ajanta Pharma Limited, India, and marketed by Ajanta Pharma USA Inc. It includes storage instructions, a barcode, and placeholder space for lot and expiration dates.*
FDA Label Image

5mg-40mg (Amlodipine And Olmesartan 5 40mg)

5mg-40mg (Amlodipine And Olmesartan 5 40mg)
Label for Amlodipine and Olmesartan Medoxomil Tablets, USP, 5 mg/40 mg strength. The label indicates a package containing 30 oral tablets. Manufactured by Ajanta Pharma Limited, India, and marketed by Ajanta Pharma USA Inc., Bridgewater, NJ. It includes storage instructions and space for lot and expiry date information.*
FDA Label Image

10mg-20mg (Amlodipine And Olmesartan 10 20mg)

10mg-20mg (Amlodipine And Olmesartan 10 20mg)
Label for Amlodipine and Olmesartan Medoxomil Tablets USP, 10 mg/20 mg strength, in a package of 30 tablets. The label lists Ajanta Pharma Limited, India as manufacturer and Ajanta Pharma USA Inc. as marketer. Storage instructions specify controlled room temperature. Includes NDC 27241-085-03 and a barcode.*
FDA Label Image

10mg-40mg (Amlodipine And Olmesartan 10 40mg)

10mg-40mg (Amlodipine And Olmesartan 10 40mg)
Label for Amlodipine and Olmesartan Medoxomil Tablets USP 10 mg/40 mg, oral tablets in a 30-tablet package. Manufactured by Ajanta Pharma Limited, India, and marketed by Ajanta Pharma USA Inc. The label includes storage instructions, NDC number 27241-086-03, and space for lot and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.